MedPath

Study on the therapeutic effect and mechanism of all regulation of acupuncture and moxibustionon postmenopausal osteoporosis

Not Applicable
Conditions
Postmenopausal osteoporosis
Registration Number
ITMCTR2200005922
Lead Sponsor
Affiliated Hospital of Yunnan University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

1. All cases met the above diagnostic criteria of TCM and Western medicine;
2.46 years old = age =75 years old, and more than 1 year of natural menopause;
3. Patients who were able to receive complete 6 months of medication (calcium carbonate D3 and alendronate sodium), PEMF and holistic adjustment acupuncture (including warm acupuncture, seven-star acupuncture, cupping and cupping), and did not receive other medications or other related interventions for postmenopausal osteoporosis in the last 6 months;
4. Voluntarily participate in the study and sign the informed consent for treatment.
(Note: Only those who meet the above four criteria can be included in the study)

Exclusion Criteria

1. Women with abnormal anatomical structure of the lumbar spine (such as severe scoliosis) were excluded;
2. Exclude endocrine disorders related to secondary osteoporosis (such as diabetes, hyperthyroidism, hypothyroidism, thyroid cysts, etc.);
3. Removal of uterus or ovary;
4. Concomitant diseases such as chondrosis, rheumatoid arthritis or other diseases that affect the dynamic balance of bone metabolism;
5. Have taken drugs that can interfere with bone metabolism (such as glucocorticoid, calcitonin, estrogen, etc.) in the last 6 months;
6. Patients with serious underlying diseases and mental diseases;
7. Drug or alcohol abuse;
8. Female patients with mental disorders who cannot comply with the treatment research program;
9. Subjects who are participating in other exclusion criteria in Paragraph 1 should be excluded.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
bone mineral density;Amino terminal propeptide of serum type ? procollagen;Tartrate-resistant acid phosphatase;Bone-specific alkaline phosphatase;Bone resorption marker serum ß -i collagen carboxy-terminal peptide;
Secondary Outcome Measures
NameTimeMethod
TCM syndrome score;visual analogue scale;Follicle-stimulating hormone;estradiol;Quality of Life Scale score;
© Copyright 2025. All Rights Reserved by MedPath